Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amber N Edinoff

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Health Psychology Research|July 1, 2022
Chronic Synthetic Marijuana Use: A Case of First-Onset Seizures as a Withdrawal SymptomAmber N Edinoff, Prithvi Doppalapudi, Juliana M Fort
Journal of the Academy of Consultation-Liaison Psychiatry|February 20, 2025
Unnecessary Use of Medications for Alcohol Withdrawal Among Hospitalized Patients: A Retrospective Study of Phosphatidylethanol Testing in Patients With Suspected Alcohol Use DisorderPooja R Sarkar, Amber N Edinoff, Joji Suzuki
Health Psychology Research|August 24, 2022
Silent Neuroleptic Malignant Syndrome: A Case Report of Atypical Antipsychotic Induced Elevation of Creatinine Kinase and Altered Mental StatusAmber N Edinoff, Hamza Mohammad-Amin, Amira S Odisho
Substance Abuse and Rehabilitation|August 16, 2023
Updated Perspectives on the Neurobiology of Substance Use Disorders Using NeuroimagingKevin S Murnane, Amber N Edinoff, Elyse M Cornett, et al.
The American Journal on Addictions|February 6, 2024
The possible clinical utility of the alcohol biomarker phosphatidylethanol for managing suspected alcohol withdrawal in hospitalized patients: A case reportAmber N Edinoff, David B Hathaway, David Martinez Garza, et al.
Health Psychology Research|February 2, 2022
Valbenazine for the Treatment of Adults with Tardive DyskinesiaHarshit Gupta, Alycee R Moity, Allison Jumonville, et al.
The American Journal on Addictions|April 9, 2024
A complex psychosocial portrait of substance use disorders among Indigenous people in the United States: A scoping reviewAmber N Edinoff, Tara L Maudrie, Carly Chiwiwi, et al.
Orthopedic Reviews|June 30, 2022
Descriptive epidemiology of orthopedic injury and illness during the Special Olympics of Pennsylvania Summer Games from 2008 to 2017James D Galdieri, Alka Sood, Amber N Edinoff, et al.
Neurology International|March 24, 2022
Antipsychotic Polypharmacy-Related Cardiovascular Morbidity and Mortality: A Comprehensive ReviewAmber N Edinoff, Emily D Ellis, Laura M Nussdorf, et al.
Health Psychology Research|August 1, 2022
Viloxazine, a Non-stimulant Norepinephrine Reuptake Inhibitor, for the Treatment of Attention Deficit Hyperactivity Disorder: A 3 Year UpdateHannah W Haddad, Paul B Hankey, Jimin Ko, et al.
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Health Psychology Research|July 1, 2022
Chronic Synthetic Marijuana Use: A Case of First-Onset Seizures as a Withdrawal SymptomAmber N Edinoff, Prithvi Doppalapudi, Juliana M Fort
Journal of the Academy of Consultation-Liaison Psychiatry|February 20, 2025
Unnecessary Use of Medications for Alcohol Withdrawal Among Hospitalized Patients: A Retrospective Study of Phosphatidylethanol Testing in Patients With Suspected Alcohol Use DisorderPooja R Sarkar, Amber N Edinoff, Joji Suzuki
Health Psychology Research|August 24, 2022
Silent Neuroleptic Malignant Syndrome: A Case Report of Atypical Antipsychotic Induced Elevation of Creatinine Kinase and Altered Mental StatusAmber N Edinoff, Hamza Mohammad-Amin, Amira S Odisho
Substance Abuse and Rehabilitation|August 16, 2023
Updated Perspectives on the Neurobiology of Substance Use Disorders Using NeuroimagingKevin S Murnane, Amber N Edinoff, Elyse M Cornett, et al.
The American Journal on Addictions|February 6, 2024
The possible clinical utility of the alcohol biomarker phosphatidylethanol for managing suspected alcohol withdrawal in hospitalized patients: A case reportAmber N Edinoff, David B Hathaway, David Martinez Garza, et al.
Health Psychology Research|February 2, 2022
Valbenazine for the Treatment of Adults with Tardive DyskinesiaHarshit Gupta, Alycee R Moity, Allison Jumonville, et al.
The American Journal on Addictions|April 9, 2024
A complex psychosocial portrait of substance use disorders among Indigenous people in the United States: A scoping reviewAmber N Edinoff, Tara L Maudrie, Carly Chiwiwi, et al.
Orthopedic Reviews|June 30, 2022
Descriptive epidemiology of orthopedic injury and illness during the Special Olympics of Pennsylvania Summer Games from 2008 to 2017James D Galdieri, Alka Sood, Amber N Edinoff, et al.
Neurology International|March 24, 2022
Antipsychotic Polypharmacy-Related Cardiovascular Morbidity and Mortality: A Comprehensive ReviewAmber N Edinoff, Emily D Ellis, Laura M Nussdorf, et al.
Health Psychology Research|August 1, 2022
Viloxazine, a Non-stimulant Norepinephrine Reuptake Inhibitor, for the Treatment of Attention Deficit Hyperactivity Disorder: A 3 Year UpdateHannah W Haddad, Paul B Hankey, Jimin Ko, et al.
Pageof 8